These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38536449)

  • 1. Evaluation of systemic immune-inflammation index for predicting late-onset fetal growth restriction.
    Firatligil FB; Sucu ST; Tuncdemir S; Saglam E; Dereli ML; Ozkan S; Reis YA; Yucel KY; Celen S; Caglar AT
    Arch Gynecol Obstet; 2024 Jul; 310(1):433-439. PubMed ID: 38536449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delta neutrophil index (DNI) as a potential biomarker for fetal growth restriction: insights from maternal hematological changes and neonatal outcomes.
    Tonyali NV; Sarsmaz K; Bayraktar B; Kahraman NC; Sucu ST; Aktemur G; Cakir BT; Seyhanli Z; Karabay G; Cakir A; Ustun Y
    BMC Pregnancy Childbirth; 2024 Oct; 24(1):655. PubMed ID: 39375632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can maternal inflammatory and nutritional status, evaluated by the hemoglobin, albumin, lymphocyte, and platelet (HALP) score and the prognostic nutritional index (PNI) in the first trimester, predict late-onset fetal growth restriction?
    Seyhanli Z; Bayraktar B; Karabay G; Filiz AA; Bucak M; Agaoglu RT; Ulusoy CO; Kolomuc T; Yucel KY; Yilmaz ZV
    BMC Pregnancy Childbirth; 2024 Oct; 24(1):620. PubMed ID: 39354394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Inflammatory Markers and Doppler Parameters in Late-Onset Fetal Growth Restriction: A Machine-Learning Approach.
    Ulusoy CO; Kurt A; Seyhanli Z; Hizli B; Bucak M; Agaoglu RT; Oguz Y; Yucel KY
    Am J Reprod Immunol; 2024 Oct; 92(4):e70004. PubMed ID: 39422068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental pathology lesions: International Society for Ultrasound in Obstetrics and Gynecology vs Society for Maternal-Fetal Medicine fetal growth restriction definitions.
    Rodriguez-Sibaja MJ; Lopez-Diaz AJ; Valdespino-Vazquez MY; Acevedo-Gallegos S; Amaya-Guel Y; Camarena-Cabrera DM; Lumbreras-Marquez MI
    Am J Obstet Gynecol MFM; 2024 Aug; 6(8):101422. PubMed ID: 38969177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Inflammatory Hematological Parameters be a Guide to Late-onset Fetal Growth Restriction?
    Kırmızı DA; Baser E; Onat T; Caltekin MD; Kara M; Yalvac ES
    Z Geburtshilfe Neonatol; 2020 Oct; 224(5):262-268. PubMed ID: 32590874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Doppler ultrasound at time of diagnosis of late-onset fetal growth restriction in predicting adverse perinatal outcome: prospective cohort study.
    Rizzo G; Mappa I; Bitsadze V; Słodki M; Khizroeva J; Makatsariya A; D'Antonio F
    Ultrasound Obstet Gynecol; 2020 Jun; 55(6):793-798. PubMed ID: 31343783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-trimester screening with specific algorithms for early- and late-onset fetal growth restriction.
    Crovetto F; Triunfo S; Crispi F; Rodriguez-Sureda V; Roma E; Dominguez C; Gratacos E; Figueras F
    Ultrasound Obstet Gynecol; 2016 Sep; 48(3):340-8. PubMed ID: 26846589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying late-onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks' gestation.
    Whitehead CL; McNamara H; Walker SP; Alexiadis M; Fuller PJ; Vickers DK; Hannan NJ; Hastie R; Tuohey L; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Apr; 214(4):521.e1-521.e8. PubMed ID: 26880734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal serum midkine level in fetal growth restriction: a case-control study.
    Oluklu D; Beser DM; Hendem DU; Kara O; Yazihan N; Sahin D
    J Perinat Med; 2023 Mar; 51(3):396-402. PubMed ID: 35607756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of first-trimester systemic immune-inflammation index for the prediction of gestational diabetes mellitus.
    Bozbay N; Medinaeva A; Akyürek F; Orgul G
    Rev Assoc Med Bras (1992); 2024; 70(10):e20240532. PubMed ID: 39356958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of Serum Amphiregulin Concentrations in Pregnant Women Diagnosed with Isolated Fetal Growth Restriction in the Third Trimester.
    Ramadan FİA; Kale İ; Kobal BB; Ozel A; Muhcu M
    Z Geburtshilfe Neonatol; 2024 Apr; 228(2):161-165. PubMed ID: 37625442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of late-onset fetal growth restriction using a combined first- and second-trimester screening model.
    Feng Y; Zheng H; Fang D; Mei S; Zhong W; Zhang G
    J Gynecol Obstet Hum Reprod; 2022 Feb; 51(2):102273. PubMed ID: 34813940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrated approach based on advanced CTG parameters and Doppler measurements for late growth restriction management.
    Esposito G; Pini N; Tagliaferri S; Campanile M; Zullo F; Magenes G; Maruotti GM; Signorini MG
    BMC Pregnancy Childbirth; 2021 Nov; 21(1):775. PubMed ID: 34784882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age.
    Garcia-Manau P; Mendoza M; Bonacina E; Garrido-Gimenez C; Fernandez-Oliva A; Zanini J; Catalan M; Tur H; Serrano B; Carreras E
    Acta Obstet Gynecol Scand; 2021 Jan; 100(1):119-128. PubMed ID: 32860218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of fetal growth restriction using estimated fetal weight vs a combined screening model in the third trimester.
    Miranda J; Rodriguez-Lopez M; Triunfo S; Sairanen M; Kouru H; Parra-Saavedra M; Crovetto F; Figueras F; Crispi F; Gratacós E
    Ultrasound Obstet Gynecol; 2017 Nov; 50(5):603-611. PubMed ID: 28004439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Better prediction for FGR (fetal growth restriction) with the sFlt-1/PIGF ratio: A case-control study.
    Visan V; Scripcariu IS; Socolov D; Costescu A; Rusu D; Socolov R; Avasiloaiei A; Boiculese L; Dimitriu C
    Medicine (Baltimore); 2019 Jun; 98(26):e16069. PubMed ID: 31261515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of serum afamin concentration in pregnant women diagnosed with late fetal growth restriction or small for gestational age fetus.
    Alakbarova L; Kale İ; Muhcu M
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2240468. PubMed ID: 37518071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome-based comparison of SMFM and ISUOG definitions of fetal growth restriction.
    Roeckner JT; Pressman K; Odibo L; Duncan JR; Odibo AO
    Ultrasound Obstet Gynecol; 2021 Jun; 57(6):925-930. PubMed ID: 33798274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-trimester and combined first- and second-trimester prediction of small-for-gestational age and late fetal growth restriction.
    Sotiriadis A; Figueras F; Eleftheriades M; Papaioannou GK; Chorozoglou G; Dinas K; Papantoniou N
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):55-61. PubMed ID: 29573501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.